SINGAPORE (Reuters) – Singapore’s Health Sciences Authority (HSA) said on Monday it has granted an interim authorisation for Novavax’s COVID-19 vaccine.
The first batch of the Nuvaxovid vaccine is expected to arrive in Singapore in the next few months, the HSA said.
(Reporting by Aradhana Aravindan in Singapore; Editing by Ed Davies)
